The Impact of Donor Variables on the Outcome of Orthotopic Liver Transplantation for Hepatitis C

Transplantation Proceedings

Volumn 40, Issue 1, 2008, Pages 219-223

  Yagci, G ^a,b   Fernandez, L A ^a   Knechtle, S J ^a   D'Alessandro, A M ^a   Chin, L T ^a   Musat, A I ^a   Lucey, M R ^a   Said, A ^a   Pirsch, J D ^a   Leverson, G ^a   Kalayoglu, M ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c MEMORIAL HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEART DEATH; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CADAVER; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 38749092944     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.11.058     Document Type: Article

References (26)

1. Forman L.M., Lewis J.D., Berlin J.A., et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122 (2002) 889
2. Khalili M., Vardanian A.J., Hamerski C.M., et al. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant 20 (2006) 1
3. Neumann U.P., Berg T., Bahra M., et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 41 (2004) 830
4. Berenguer M. Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl 9 (2003) S44
5. Gane E.J., Portmann B.C., Naoumov N.V., et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334 (1996) 815
6. Berenguer M. What determines the natural history of recurrent hepatitis C after liver transplantation?. J Hepatol 42 (2005) 448
7. Foley D.P., Fernandez L.A., Leverson G., et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 242 (2005) 724
8. Marino I.R., Doyle H.R., Doria C., et al. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 27 (1995) 1184
9. Buckel E., Sanchez-Urdazpal L., Steers J., et al. Impaired initial function in liver grafts from donors >50 years of age. Transplant Proc 25 (1993) 1558
10. Greig P.D., Forster J., Superina R.A., et al. Donor-specific factors predict graft function following liver transplantation. Transplant Proc 22 (1990) 2072
11. Yersiz H., Shaked A., Olthoff K., et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 60 (1995) 790
12. Berenguer M., Prieto M., San Juan F., et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36 (2002) 202
13. Machicao V.I., Bonatti H., Krishna M., et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 77 (2004) 84
14. Sheiner P.A., Schwartz M.E., Mor E., et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21 (1995) 30
15. Alonso O., Loinaz C., Moreno E., et al. Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation. Transplant Int 18 (2005) 902
16. Manez R., Mateo R., Tabasco J., et al. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 59 (1995) 640
17. Doughty A.L., Spencer J.D., Cossart Y.E., et al. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 4 (1998) 15
18. Berenguer M., Crippin J., Gish R., et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology 38 (2003) 34
19. Gayowski T., Singh N., Marino I.R., et al. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 64 (1997) 422
20. Vargas H.E., Laskus T., Wang L.F., et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 4 (1998) 22
21. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 (2000) 673
22. Wali M., Harrison R.F., Gow P.J., et al. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 51 (2002) 248
23. Sigal S.H., Rajvanshi P., Gorla G.R., et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 276 (1999) G1260
24. D'Alessandro A.M., Hoffmann R.M., Knechtle S.J., et al. Liver transplantation from controlled non- heart-beating donors. Surgery 128 (2000) 579
25. Furukawa H., Todo S., Imventarza O., et al. Cold ischemia time vs outcome of human liver transplantation using UW solution. Transplant Proc 23 (1991) 1550
26. Lee K.W., Simpkins C.E., Montgomery R.A., et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 82 (2006) 1683